CRISPR-Cas
| CRISPR Medicine |
CRISPR-Cas
| CRISPR Medicine |
IND Enabling
Phase I
Phase II
Phase III
Recurrent or Progressive High-grade Glioma, (NCT06737146)
Sponsors:
Suzhou Maximum Bio-tech Co., Ltd.
Sponsors:
Suzhou Maximum Bio-tech Co., Ltd.
IND Enabling
Phase I
Phase II
Phase III
Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma, (NCT06815029)
Sponsors:
City of Hope Medical Center
Sponsors:
City of Hope Medical Center
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
Brain, Meninges, and Spinal Cord Metastatic Solid Tumors, (NCT06742593)
Sponsors:
Suzhou Maximum Bio-tech Co., Ltd.
Sponsors:
Suzhou Maximum Bio-tech Co., Ltd.
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
Heterozygous familial hypercholesterolemia, (ChiCTR2400093099)
Sponsors:
Primary sponsor: The First Affiliated Hospital of Bengbu Medical College Primary sponsor's address: 287 Changhuai Road, Longzihu District, Bengbu, Anhui, China Secondary sponsor: Country: China Province: Anhui City: Bengbu Institution hospital: The First Affiliated Hospital of Bengbu Medical College Address: 287 Changhuai Road, Longzihu District
Sponsors:
Primary sponsor: The First Affiliated Hospital of Bengbu Medical College Primary sponsor's address: 287 Changhuai Road, Longzihu District, Bengbu, Anhui, China Secondary sponsor: Country: China Province: Anhui City: Bengbu Institution hospital: The First Affiliated Hospital of Bengbu Medical College Address: 287 Changhuai Road, Longzihu District
IND Enabling
Phase I
Phase II
Phase III